Lymphoma Research Foundation company information, Employees & Contact Information

Lymphoma - Diagnosis and treatment Mayo Clinic

Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma | Journal of Clinical Oncology ASCO Publications

Lymphoma - Symptoms and causes Mayo Clinic

Lymphoma Research Foundation Elects Whitney Neighbors to Board of Directors PRWeb

Lymphoma Research Foundation Elects Ellen M. Walker to Board of Directors PRWeb

Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma The New England Journal of Medicine

Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study Nature

Lymphoma - what is it, symptoms and treatment Blood Cancer UK

Long-Term Outcomes of Primary Cardiac Lymphoma | Circulation American Heart Association Journals

Plasmablastic lymphoma: current knowledge and future directions Frontiers

Department of Lymphoma & Myeloma MD Anderson Cancer Center

Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma The New England Journal of Medicine

Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial | Journal of Clinical Oncology ASCO Publications

Carcinogenic mechanisms of virus-associated lymphoma Frontiers

Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma The New England Journal of Medicine

Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma The New England Journal of Medicine

Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma The New England Journal of Medicine

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma The New England Journal of Medicine

Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma The New England Journal of Medicine

Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children The New England Journal of Medicine

Expert interview: The many types of lymphomas mcpress.mayoclinic.org

Diffuse Large B-Cell Lymphoma The New England Journal of Medicine

Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study | Journal of Clinical Oncology ASCO Publications

KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma The New England Journal of Medicine

Burkitt’s Lymphoma The New England Journal of Medicine

Aggressive Lymphoma after CD19 CAR T-Cell Therapy The New England Journal of Medicine

Molecular Diagnosis of Burkitt's Lymphoma The New England Journal of Medicine

Targeting the Bcl-2 Family in B Cell Lymphoma Frontiers

Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy The New England Journal of Medicine

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma The New England Journal of Medicine

From discovery to differentiation: Why subtypes matter in lymphoma Roche

Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma The New England Journal of Medicine

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma The New England Journal of Medicine

Clinical Features of 50 Patients With Primary Adrenal Lymphoma Frontiers

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma The New England Journal of Medicine

Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas The New England Journal of Medicine

Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report Frontiers

Lymphoma Research Foundation Recognizes Blood Cancer Awareness Month With Light it Red for Lymphoma Campaign Bionews

Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma The New England Journal of Medicine

Interim PET in Diffuse Large B-Cell Lymphoma Journal of Nuclear Medicine

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma The New England Journal of Medicine

The genomic and transcriptional landscape of primary central nervous system lymphoma Nature

PET/CT for Therapy Response Assessment in Lymphoma Journal of Nuclear Medicine

Follicular lymphoma: 2023 update on diagnosis and management Wiley Online Library

Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma Haematologica

Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma The New England Journal of Medicine

Lymphoma Research Foundation Rebrands to Reflect Its Unifying Role Within the Lymphoma Community PRWeb

Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis Journal of Hematology & Oncology

Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma The New England Journal of Medicine

PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma The New England Journal of Medicine

Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma The New England Journal of Medicine

Low-Intensity Therapy in Adults with Burkitt's Lymphoma The New England Journal of Medicine

Lymphoma Research Foundation to Honor Leading Lymphoma Expert Anas Younes, MD at 2019 Annual Gala on September 26 PRWeb

Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma The New England Journal of Medicine

Dose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastinal B-Cell Lymphoma The New England Journal of Medicine

The IL ‐6 signaling complex is a critical driver, negative prognostic factor, and therapeutic target in diffuse large B‐cell lymphoma EMBO Press

Primary Bone Lymphoma: A Case Series and Review of Literature - Bindal - 2020 - Case Reports in Hematology Wiley Online Library

Study: Glyphosate Doubles Risk of Lymphoma Environmental Working Group

Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review Haematologica

Margraf puts coaching Delaware Hayes girls basketball on hold to support daughter The Columbus Dispatch

Lymphoma Research Foundation Raises More than $140,000 at Annual Fashion Luncheon for Blood Cancer Research and Education PRWeb

Lymphoma – what’s that? Open Access Government

A Predictive Model for Aggressive Non-Hodgkin's Lymphoma The New England Journal of Medicine

Actor Michael C Hall Recovered from Hodgkin Lymphoma empowher.com